|
|
An innovator of eClinical
In 1998, clinical research professionals founded PharmaLink with a singular vision: Use advances in Internet-based technology and security to simplify and revolutionize the clinical trial process. Through an infusion of capital and an affiliation with Family Health International in 1999, PharmaLink (thereafter called PharmaLinkFHI) realized its ambitious goal to become a global, full-service eCRO. Since then, we've expanded our clinical teams, refined our processes, fully integrated data capture and project management technology, and increased our global reach. The advantage to our Sponsors is two-fold: You can now manage trials online with maximum speed and efficiency, as well as conduct studies from virtually anywhere in the world.
Clinical research experts
Combining backgrounds from both traditional CROs and biopharmaceutical and device companies, PharmaLink teams know clinical development. In fact, PharmaLink's expertise is all-inclusive, crossing wide-ranging therapeutic categories (anti-infective to urology) and functional operations (clinical monitoring to quality assurance). With the advent of new and enhanced technologies—including increased Internet security and usage—we knew there was a better, more efficient way to run clinical trials.
eClinical is the integration of people + technology + processes
Introducing technology to paper-based processes is simply the worst of both worlds creating huge redundancies and mounting frustrations. As an eCRO pioneer, PharmaLink developed SOPs based on leveraging technology, to achieve efficient sharing of study information and resources from multiple locations. Combined with our highly seasoned and therapeutically diverse staff, our project teams meld clinical, therapeutic and technological know-how to enable a comprehensive electronic trial. The results are convincing: effective program implementation, efficient resource utilization and improved data quality at every stage of a study. Simply stated, PharmaLink delivers smarter trials. |
|

|
|